Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients

被引:57
作者
Ferguson, MK [1 ]
Durkin, A [1 ]
机构
[1] Univ Chicago, Dept Surg, Chicago, IL 60637 USA
关键词
surveillance; endoscopic; Barrett's; neoplasm; esophagus; adenocarcinoma; columnar-lined;
D O I
10.1016/S1091-255X(01)00052-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
There is growing controversy over the cost-effectiveness of surveillance endoscopy for patients with Barrett's esophagus. A retrospective review was performed of 80 patients who underwent resection for Barrett's adenocarcinoma to assess the influence of endoscopic surveillance on long-term survival. Twelve patients initially were diagnosed with benign Barrett's esophagus and were followed with endoscopic surveillance. The remaining 68 patients had the diagnosis of Barrett's esophagus made at the time of their cancer diagnosis or resection. Patients in surveillance programs were younger (53 vs. 64 years; P = 0.008), had better performance status (8.9 vs. 8.2; P = 0.04), had less weight loss (0.3 vs. 5.5 kg; P < 0.001), had a similar incidence of gastroesophageal reflux disease symptoms (75% vs. 60%), and were less likely to undergo preoperative chemotherapy and/or radiation therapy (8% vs. 28%). Pathologic stage was 0 or I in 9 (75%) of 12 patients in the surveillance group compared to 12 (18%) of 68 of those in the no surveillance group (P < 0.001). Median survival for patients in the surveillance group was 107 months compared to 12 months for those in the no surveillance group (P < 0.001). Stratifying for stage, surveillance (hazard ratio = 3.05; confidence interval = 1.09 to 8.57; P = 0.034) was the only predictor of survival. Surveillance endoscopy permits early diagnosis of adenocarcinoma in patients with Barrett's esophagus and contributes substantially to long-term survival.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 33 条
  • [1] *AM JOINT COMM CAN, 1997, AJCC CANC STAG MAN, P65
  • [2] Advances in radiology and the real versus apparent effects of early diagnosis
    Black, WC
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 1998, 27 (02) : 116 - 122
  • [3] SMALL RENAL PARENCHYMAL NEOPLASMS - FURTHER OBSERVATIONS ON GROWTH
    BOSNIAK, MA
    BIRNBAUM, BA
    KRINSKY, GA
    WAISMAN, J
    [J]. RADIOLOGY, 1995, 197 (03) : 589 - 597
  • [4] Bytzer P, 1999, AM J GASTROENTEROL, V94, P86
  • [5] THE RELATION OF GASTROESOPHAGEAL REFLUX DISEASE AND ITS TREATMENT TO ADENOCARCINOMAS OF THE ESOPHAGUS AND GASTRIC CARDIA
    CHOW, WH
    FINKLE, WD
    MCLAUGHLIN, JK
    FRANKL, H
    ZIEL, HK
    FRAUMENI, JF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (06): : 474 - 477
  • [6] Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux
    Csendes, A
    Smok, G
    Burdiles, P
    Quesada, F
    Huertas, C
    Rojas, J
    Korn, O
    [J]. DISEASES OF THE ESOPHAGUS, 2000, 13 (01): : 5 - 11
  • [7] Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO
  • [8] 2-U
  • [9] Endoscopic surveillance of Barrett's esophagus: risk stratification and cancer risk
    Falk, GW
    [J]. GASTROINTESTINAL ENDOSCOPY, 1999, 49 (03) : S29 - S34
  • [10] Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer
    Farrow, DC
    Vaughan, TL
    Sweeney, C
    Gammon, MD
    Chow, WH
    Risch, HA
    Stanford, JL
    Hansten, PD
    Mayne, ST
    Schoenberg, JB
    Rotterdam, H
    Ahsan, H
    West, AB
    Dubrow, R
    Fraumeni, JF
    Blot, WJ
    [J]. CANCER CAUSES & CONTROL, 2000, 11 (03) : 231 - 238